Phase 2 Study of Adjuvant Intravesical Instillations of Apaziquone for High Risk Nonmuscle Invasive Bladder Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase 2 Study of Adjuvant Intravesical Instillations of Apaziquone for High Risk Nonmuscle Invasive Bladder Cancer

Published:2012-04 Issue:4 Volume:187 Page:1195-1199
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Hendricksen K.¹,Cornel E.B.²,de Reijke T.M.³,Arentsen H.C.¹,Chawla S.⁴,Witjes J.A.¹

Affiliation:

1. Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

2. Department of Urology, Twente Hospital Group, Hengelo, The Netherlands

3. Department of Urology, Academic Medical Centre, Amsterdam, The Netherlands

4. Spectrum Pharmaceuticals, Inc., Irvine, California

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference25 articles.

1. Bladder cancer: epidemiology, staging and grading, and diagnosis;Kirkali;Urology,2005

2. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update;Hall;J Urol,2007

3. Guidelines on non-muscle invasive bladder cancer (TaT1 and CIS);Babjuk,2011

4. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials;Sylvester;Eur Urol,2006

5. Apaziquone for non-muscle invasive bladder cancer: a critical review;Witjes;Expert Opin Investig Drugs,2008

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoxia within the glioblastoma tumor microenvironment: a master saboteur of novel treatments;Frontiers in Immunology;2024-06-26

2. Tumor hypoxia: From basic knowledge to therapeutic implications;Seminars in Cancer Biology;2023-01

3. Hypoxia and the Metastatic Cascade;Hypoxia in Cancer: Significance and Impact on Cancer Therapy;2023

4. The Present and Future of Intravesical Therapy in Bladder Cancer;The Korean Journal of Urological Oncology;2022-05-31

5. Directing Hypoxic Tumor Microenvironment and HIF to Illuminate Cancer Immunotherapy's Existing Prospects and Challenges in Drug Targets;Current Drug Targets;2022-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3